Attitudes toward COVID-19 Vaccination: A Survey of Chinese Patients with Rheumatic Diseases
Zixi Yi,
Zhongqiang Yao,
Dan Xu,
Chuanhui Xu,
Wenqiang Fang,
Zhanfei Guo,
Yong Wang,
Jianlin Huang,
Qin Li,
Hong Zhang,
Anbin Huang,
Lijun Wu,
Zhenbiao Wu,
Huifang Guo,
Fengxiao Zhang,
Jing Lu,
Zhenchun Zhang,
Zhongming Yu,
Zhanyun Da,
Li Luo,
Bin Wu,
Henglian Wu,
Lin Zeng,
Rong Mu
Affiliations
Zixi Yi
Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing 100191, China
Zhongqiang Yao
Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing 100191, China
Dan Xu
Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing 100191, China
Chuanhui Xu
Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore 999002, Singapore
Wenqiang Fang
Department of Rheumatology and Immunology, Xinxiang Central Hospital, Xinxiang 453000, China
Zhanfei Guo
Department of Rheumatology and Immunology, Xinxiang Central Hospital, Xinxiang 453000, China
Yong Wang
Department of Rheumatology and Immunology, The Southwest Hospital of Army Medical University, Chongqing 404100, China
Jianlin Huang
Department of Rheumatology and Immunology, Sun Yat-sen University Sixth Affiliated Hospital, Guangzhou 510275, China
Qin Li
Department of Rheumatology and Immunology, The First People’s Hospital of Yunnan Province, Kunming 650300, China
Hong Zhang
Department of Rheumatology and Immunology, The First People’s Hospital of Yunnan Province, Kunming 650300, China
Anbin Huang
Department of Rheumatology and Immunology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430074, China
Lijun Wu
Department of Rheumatology and Immunology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830001, China
Zhenbiao Wu
Department of Rheumatology and Immunology, Air Force Medical University, Xi’an 710000, China
Huifang Guo
Department of Rheumatology and Immunology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China
Fengxiao Zhang
Department of Rheumatology and Immunology, Hebei General Hospital, Shijiazhuang 050000, China
Jing Lu
Department of Rheumatology and Immunology, The First Hospital of China Medical University, Shenyang 110000, China
Zhenchun Zhang
Department of Rheumatology and Immunology, Linyi People’s Hospital, Linyi 273300, China
Zhongming Yu
Department of Rheumatology and Immunology, Shaoxing People’s Hospital, Shaoxing 310009, China
Zhanyun Da
Department of Rheumatology and Immunology, Affiliated Hospital of Nantong University, Nantong 226001, China
Li Luo
Department of Rheumatology and Immunology, Xinjiang Medical University Affiliated First Hospital, Urumqi 830001, China
Bin Wu
Department of Rheumatology and Immunology, First People’s Hospital of Jingzhou, Jingzhou 434000, China
Henglian Wu
Department of Rheumatology and Immunology, Dongguan Tungwah Hospital, Dongguan 523000, China
Lin Zeng
Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing 100191, China
Rong Mu
Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing 100191, China
The coronavirus disease 2019 (COVID-19) pandemic has imposed enormous morbidity and mortality burdens. Patients with rheumatic diseases (RDs) are vulnerable to the COVID-19 infection, given their immunocompromised status. Ensuring acceptance of the COVID-19 vaccine is important and has attracted attention by health professionals. In this study, we designed an online cross-sectional survey that used an online questionnaire from 8 May 2021 to 4 October 2021. Attitudes toward the COVID-19 vaccination, personal information, current disease activity status, adverse events (AEs), and knowledge sources of vaccines were collected. Descriptive statistics, nonparametric tests, and ordinal logistic regression were used to analyze the data. A total of 1022 questionnaires were received, among which 70.2% (720/1022) of patients with RDs agreed to vaccination, while only 31.6% of patients were actually vaccinated. Male, employed, high-income patients and those with inactive disease showed a more positive attitude. Concerns of AEs and disease flare were the main factors affecting vaccination willingness. Only 29.6% (304/1022) of patients thought they had received enough information about the COVID-19 vaccine from their doctors. In conclusion, most patients with RDs in China intended to get vaccinated, although the vaccination rate in this particular population was low. Rheumatologists should take more responsibility in COVID-19 vaccination education of patients with RDs.
